<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Epidemiol Infect</journal-id><journal-id journal-id-type="iso-abbrev">Epidemiol Infect</journal-id><journal-id journal-id-type="publisher-id">HYG</journal-id><journal-title-group><journal-title>Epidemiology and Infection</journal-title></journal-title-group><issn pub-type="ppub">0950-2688</issn><issn pub-type="epub">1469-4409</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32958091</article-id><article-id pub-id-type="pmc">7533483</article-id><article-id pub-id-type="doi">10.1017/S0950268820002162</article-id><article-id pub-id-type="pii">S0950268820002162</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>A model of COVID-19 transmission to understand the effectiveness of the containment measures: application to data from France</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0025-0272</contrib-id><name><surname>Zongo</surname><given-names>P.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Zorom</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mophou</surname><given-names>G.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Dorville</surname><given-names>R.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Beaumont</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Laboratoire L3MA, DSI et IUT, <institution>Universit&#x000e9; des Antilles</institution>, <city>Schoelcher</city>, <country>Martinique</country></aff><aff id="aff2"><label>2</label><institution>Institute 2iE</institution>, B.P. 594, <city>Ouagadougou</city>, <country>Burkina Faso</country></aff><aff id="aff3"><label>3</label>Laboratoire LAMIA, <institution>Universit&#x000e9; des Antilles</institution>, Campus de Fouillole, 97159, Pointe &#x000e0; Pitre Guadeloupe (FWI) &#x02013; Laboratoire MAINEGE, Universit&#x000e9; Ouaga 3S, 06 BP <postal-code>10347</postal-code>
<city>Ouagadougou</city> 06, <country>Burkina Faso</country></aff><aff id="aff4"><label>4</label><institution>INRAE, Universit&#x000e9; de Tours, UMR Biologie des oiseaux et aviculture</institution>, <postal-code>F-37380</postal-code>
<city>Nouzilly</city>, <country>France</country></aff><author-notes><corresp id="cor1"><bold>Author for correspondence:</bold> P. Zongo, E-mail: <email>Pascal.Zongo@gmail.com</email></corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2020"><year>2020</year></pub-date><pub-date pub-type="epub"><day>22</day><month>9</month><year>2020</year></pub-date><volume>148</volume><elocation-id>e221</elocation-id><history><date date-type="received"><day>29</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>25</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>27</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0950268820002162a.pdf"/><abstract abstract-type="normal"><p>The main objective of this paper is to address the following question: are the containment measures imposed by most of the world governments effective and sufficient to stop the epidemic of COVID-19 beyond the lock-down period? In this paper, we propose a mathematical model which allows us to investigate and analyse this problem. We show by means of the reproductive number, <inline-formula><inline-graphic xlink:href="S0950268820002162_inline1.jpg" mime-subtype="png" mimetype="image"/></inline-formula> that the containment measures appear to have slowed the growth of the outbreak. Nevertheless, these measures remain only effective as long as a very large fraction of population, <italic>p</italic>, greater than the critical value <inline-formula><inline-graphic xlink:href="S0950268820002162_inline2.jpg" mime-subtype="png" mimetype="image"/></inline-formula> remains confined. Using French current data, we give some simulation experiments with five scenarios including: (i) the validation of model with <italic>p</italic> estimated to 93%, (ii) the study of the effectiveness of containment measures, (iii) the study of the effectiveness of the large-scale testing, (iv) the study of the social distancing and wearing masks measures and (v) the study taking into account the combination of the large-scale test of detection of infected individuals and the social distancing with linear progressive easing of restrictions. The latter scenario was shown to be effective at overcoming the outbreak if the transmission rate decreases to 75% and the number of tests of detection is multiplied by three. We also noticed that if the measures studied in our five scenarios are taken separately then the second wave might occur at least as far as the parameter values remain unchanged.</p></abstract><kwd-group><title>Key words</title><kwd>Basic reproduction ratio</kwd><kwd>containment measures</kwd><kwd>COVID-19</kwd><kwd>new wave</kwd></kwd-group><counts><fig-count count="7"/><table-count count="1"/><ref-count count="35"/><page-count count="12"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>In December 2019, a disease that appeared in central China precisely in the city of Wuhan (Hubei Province) started to take its toll. On 7 January 2020, Chinese authorities admitted that the country was facing an epidemic caused by a new virus from the coronavirus family. First named &#x02018;2019-nCOV&#x02019;, this virus and disease was named COVID-19 or SARS-CoV-2 by the World Health Organization (WHO) [<xref rid="ref1" ref-type="bibr">1</xref>]. COVID-19 disease has passed in a few weeks from a localised epidemic to a pandemic. This disease is now a public health emergency at the international level and is currently affecting more than 200 countries with more than 350&#x000a0;000 deaths and nearly 6 million people infected according to the WHO. It is contagious with human-to-human transmission via respiratory droplets or by touching contaminated surfaces and then touching one's face. The most common symptoms are fever, cough and difficulty breathing, but it can cause acute respiratory distress, which is often fatal.</p><p>The spread of the disease has enormous consequences for all sectors of society, endangering economics of almost all countries in the world. In the current state of knowledge, there is no preventive vaccine, biomedical means of prevention or specific therapeutic means. International, national and local control strategies are essentially based on barrier measures, social distancing, wearing masks, confinement, screening and diagnosis according to various methods and symptomatic treatment. Today in different countries, research in all its dimensions has become an absolute priority. In particular any research which can help to understand, prevent and treat COVID-19 is encouraged at the highest political level of many countries. Following this urgency, models have already been proposed in order to study the dynamics and to control the pandemic [<xref rid="ref2" ref-type="bibr">2</xref>&#x02013;<xref rid="ref9" ref-type="bibr">9</xref>]. In this paper, we propose a new model which could help to understand the effectiveness of the containment measures adopted across countries. The model will be used to predict different scenarios of the possible resurgences of the new waves of epidemic in France.</p><p>The paper is organised as follows. The next section presents the model. The basic reproduction ratio is established in Section &#x02018;Basic reproduction number&#x02019;. Section &#x02018;Construction of the containment rate&#x02019; is devoted to the formulation of the function which regulates the containment measures. In section &#x02018;Model parameters&#x02019;, we identified the values of model parameters. Section &#x02018;Simulation experiments: application to data from France&#x02019; presents the simulation experiments for which five scenarios will be implemented: validation of model by comparison with the actual available data in France, testing the effectiveness of containment measures and longer-term forecasting of epidemic, study of the effectiveness of the large-scale testing, study of social distancing measures and the combined study of the large-scale testing and social distancing and/or wearing masks measures. Concluding remarks will follow in Section &#x02018;Discussion and conclusion&#x02019;.</p></sec><sec sec-type="other" id="sec2"><title>Model formulation</title><p>To model the COVID-19 transmission, we divide the human population into seven classes. Susceptible unconfined <italic>S</italic><sub>u</sub>(<italic>t</italic>), susceptible confined <italic>S</italic><sub>c</sub>(<italic>t</italic>), exposed <italic>E</italic>(<italic>t</italic>), reported infectious <italic>I</italic><sub>r</sub>(<italic>t</italic>), unreported infectious or silent carriers, <italic>I</italic><sub>u</sub>(<italic>t</italic>), quarantined <italic>Q</italic>(<italic>t</italic>), recovered <italic>R</italic>(<italic>t</italic>) at any time <italic>t</italic>, see in <xref ref-type="fig" rid="fig01">Figure 1</xref>.
<fig id="fig01" fig-type="fig" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>A schematic of the model for COVID-19 transmission. In this figure, <italic>S</italic><sub>u</sub> represents the number of unconfined susceptible, <italic>S</italic><sub>c</sub> denotes the number of confined susceptible, <italic>E</italic> depicts the number of exposed, <italic>I</italic><sub>r</sub> denotes the number of reported infectious, <italic>I</italic><sub>u</sub> represents the number of unreported infectious or silent carriers, <italic>R</italic> denotes the number of recovered and <italic>Q</italic> denotes the number of quarantined. The arrow shows the people moving between the compartments.</p></caption><graphic xlink:href="S0950268820002162_fig1"/></fig></p><p>In this paper, the unreported infectious individuals depict mainly the individuals with no clinical symptoms (asymptomatic or silent carriers) during their infectious period. They also include some infectious individuals with mild symptoms who thus often go unrecognised.</p><p>In what follows, we assume that these individuals don't die of the disease, while the reported infectious can die of disease at a rate (1&#x000a0;&#x02212;&#x000a0;<italic>q</italic>)<italic>&#x003b7;</italic><sub>r</sub> where 1&#x000a0;&#x02212;&#x000a0;<italic>q</italic> is the fraction of reported individuals that die, <italic>q</italic> is the fraction of reported individuals that recover and 1/<italic>&#x003b7;</italic><sub>r</sub> is the average length of infectious period of reported individuals (see <xref ref-type="fig" rid="fig01">Fig. 1</xref>).</p><p>An individual moves to the susceptible unconfined class, <italic>S</italic><sub>u</sub>, either from the confined class at a rate 1&#x000a0;&#x02212;&#x000a0;<italic>m</italic>(<italic>t</italic>) or from the quarantined class at a constant rate <italic>&#x003b8;</italic>(1&#x000a0;&#x02212;&#x000a0;<italic>&#x003bb;</italic>). The fundamental parameter that we have introduced in our model to study the containment measures is the parameter <italic>m</italic>(<italic>t</italic>), it can be interpreted as the fraction of confined susceptible individuals at any time <italic>t</italic>. When the susceptible individuals are exposed to the virus, then the exposition provides either the reported class, <italic>I</italic><sub>r</sub> or the unreported class, <italic>I</italic><sub>u</sub>. Without making any distinction about the origin of the infection, we assume that a fraction <italic>&#x003c3;</italic> of susceptible unconfined individuals which has been in contact with an infectious individual is quarantined with contact tracing while the other fraction (1&#x000a0;&#x02212;&#x000a0;<italic>&#x003c3;</italic>) who was not detected by the contact tracing move to the exposed class <italic>E</italic> once effectively infected or stay in compartment <italic>S</italic><sub>u</sub> otherwise. Then, the quantities (1&#x000a0;&#x02212;&#x000a0;<italic>&#x003c3;</italic>)(<italic>&#x003b2;</italic><sub>r</sub><italic>I</italic><sub>r</sub>&#x000a0;+&#x000a0;<italic>&#x003b2;</italic><sub>u</sub><italic>I</italic><sub>u</sub>)<italic>S</italic> and <italic>&#x003c3;</italic>(<italic>&#x003b2;</italic><sub>r</sub><italic>I</italic><sub>r</sub>&#x000a0;+&#x000a0;<italic>&#x003b2;</italic><sub>u</sub><italic>I</italic><sub>u</sub>)<italic>S</italic> represent the inflow of new individuals into the exposed class <italic>E</italic> and quarantined class <italic>Q</italic> respectively. The parameters <italic>&#x003b2;</italic><sub>r</sub> and <italic>&#x003b2;</italic><sub>u</sub> are the transmission rate of reported and unreported cases, respectively. We assume that reported individuals will participate in the infections with a lower rate than those unreported because they are generally isolated at the hospital or at home. However, they can transmit the infection to caregivers or their entourage. Moreover, they may have first been asymptomatic carriers contributing to the transmission of the virus. To simplify the notation, we set <italic>&#x003b2;</italic><sub>u</sub>&#x000a0;=&#x000a0;<italic>&#x003b2;</italic> and <italic>&#x003b2;</italic><sub>r</sub>&#x000a0;=&#x000a0;<italic>&#x000f1;&#x003b2;</italic><sub>u</sub>&#x000a0;=&#x000a0;<italic>&#x000f1;&#x003b2;</italic> where <italic>&#x000f1;</italic>&#x000a0;&#x02208;&#x000a0;[0, 1]. The parameter <italic>&#x000f1;</italic> represents the infectivity of the reported cases and for <italic>&#x000f1;</italic>&#x000a0;=&#x000a0;1, the reported and unreported have the same level of infectivity. Among the quarantined individuals, a fraction <italic>&#x003bb;</italic> of individuals are effectively infected and moves in the reported infectious class, <italic>I</italic><sub>r</sub>, after an average duration of isolation, 1/<italic>&#x003b8;</italic>, and a fraction 1&#x000a0;&#x02212;&#x000a0;<italic>&#x003bb;</italic> returns to the susceptible class without being reported infectious. We assume that only a fraction <italic>f</italic> of the individuals of exposed class becomes reported infectious and enters to the class <italic>I</italic><sub>r</sub> at a rate <italic>&#x003bc;</italic> where 1/<italic>&#x003bc;</italic> represents the average length of the exposed period while the other fraction (1&#x000a0;&#x02212;&#x000a0;<italic>f</italic>) moves to the infectious unreported infectious class <italic>I</italic><sub>u</sub> at a rate <italic>&#x003bc;</italic>.</p><p>With the above considerations, the model describing the spread of COVID-19 takes the form:<disp-formula id="eqn1"><label>1</label><graphic xlink:href="S0950268820002162_eqn1.jpg" mime-subtype="png" position="float" mimetype="image" orientation="portrait"/></disp-formula></p><p>This model (<xref ref-type="disp-formula" rid="eqn1">1</xref>) is supplemented together with initial data <italic>S</italic><sub>c</sub>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>S</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>E</italic>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>I</italic><sub>r</sub>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>I</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>R</italic>(<italic>&#x003c4;</italic><sub>0</sub>) and <italic>Q</italic>(<italic>&#x003c4;</italic><sub>0</sub>).</p><p>Let DI<sub>r</sub>(<italic>t</italic>), DI<sub>u</sub>(<italic>t</italic>), CI<sub>r</sub>(<italic>t</italic>) and CI<sub>u</sub>(<italic>t</italic>) denote the daily number of reported cases, unreported one, the cumulative number of reported cases and unreported cases respectively at any time <italic>t</italic>. These quantities are obtained by solving the following equations:<disp-formula id="eqn2"><label>2</label><graphic xlink:href="S0950268820002162_eqn2.jpg" mime-subtype="png" position="float" mimetype="image" orientation="portrait"/></disp-formula>with initial conditions DI<sub>r</sub>(<italic>&#x003c4;</italic><sub>0</sub>), DI<sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>), CI<sub>r</sub>(<italic>&#x003c4;</italic><sub>0</sub>) and CI<sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>).</p></sec><sec sec-type="other" id="sec3"><title>Basic reproduction number</title><p>The fundamental key concept in epidemiology is the basic reproduction number. Commonly denoted by <inline-formula><inline-graphic xlink:href="S0950268820002162_inline3.jpg" mime-subtype="png" mimetype="image"/></inline-formula> it is the expected number of secondary cases produced by a typical infective individual introduced into a completely susceptible population, in the absence of any control measure [<xref rid="ref10" ref-type="bibr">10</xref>, <xref rid="ref11" ref-type="bibr">11</xref>]. Mathematically, <inline-formula><inline-graphic xlink:href="S0950268820002162_inline4.jpg" mime-subtype="png" mimetype="image"/></inline-formula> is the spectral radius of the next-generation matrix. The next-generation matrix can be obtained by construction (cf. for instance [<xref rid="ref12" ref-type="bibr">12</xref>&#x02013;<xref rid="ref14" ref-type="bibr">14</xref>]). Using the method developed in [<xref rid="ref11" ref-type="bibr">11</xref>], we obtain explicit formula for <inline-formula><inline-graphic xlink:href="S0950268820002162_inline5.jpg" mime-subtype="png" mimetype="image"/></inline-formula> as follows:<disp-formula id="eqn3"><label>3</label><graphic xlink:href="S0950268820002162_eqn3.jpg" mime-subtype="png" position="float" mimetype="image" orientation="portrait"/></disp-formula>where <italic>&#x003b2;</italic><sub>u</sub>&#x000a0;=&#x000a0;<italic>&#x003b2;</italic> and <italic>&#x003b2;</italic><sub>r</sub>&#x000a0;=&#x000a0;<italic>&#x000f1;&#x003b2;</italic>. In the Appendix we give some details about the derivation of <inline-formula><inline-graphic xlink:href="S0950268820002162_inline6.jpg" mime-subtype="png" mimetype="image"/></inline-formula></p><p>The quantity <inline-formula><inline-graphic xlink:href="S0950268820002162_inline7.jpg" mime-subtype="png" mimetype="image"/></inline-formula> represents the average number of secondary infections produced by one reported infective individual during its infectious period, 1/<italic>&#x003b7;</italic><sub>r</sub>; <inline-formula><inline-graphic xlink:href="S0950268820002162_inline8.jpg" mime-subtype="png" mimetype="image"/></inline-formula> represents the average number of secondary infections produced by one unreported infective individual during its infectious period, 1/<italic>&#x003b7;</italic><sub>u</sub>.</p><p>To take into account the containment measures, the large-scale testing, the social distancing and wearing masks measures, some constant parameters such as <italic>f</italic>, <italic>&#x003c3;</italic>, <italic>&#x003b2;</italic> and <italic>S</italic><sub>u</sub>(0) will be replaced in Equation (<xref ref-type="disp-formula" rid="eqn3">3</xref>) with the aforementioned time-dependent parameters. In this case, we can define the effective daily reproduction number, <inline-formula><inline-graphic xlink:href="S0950268820002162_inline9.jpg" mime-subtype="png" mimetype="image"/></inline-formula> which measures the number of new infections produced by a single infected individual per day. This quantity is obtained by solving the following equation:<disp-formula id="eqn4"><label>4</label><graphic xlink:href="S0950268820002162_eqn4.jpg" mime-subtype="png" position="float" mimetype="image" orientation="portrait"/></disp-formula>with initial condition <inline-formula><inline-graphic xlink:href="S0950268820002162_inline10.jpg" mime-subtype="png" mimetype="image"/></inline-formula> defined in Equation (<xref ref-type="disp-formula" rid="eqn3">3</xref>).</p></sec><sec sec-type="other" id="sec4"><title>Construction of the containment rate</title><p>To analyse the effectiveness of containment measures, we assume that a fraction <italic>m</italic>(<italic>t</italic>) of susceptible individuals in the population is confined at any time <italic>t</italic>. Furthermore, we introduce a parameter <italic>p</italic> which indicates the maximum percentage of the population that the government confines. This fraction should be greater than the quantity <inline-formula><inline-graphic xlink:href="S0950268820002162_inline11.jpg" mime-subtype="png" mimetype="image"/></inline-formula> to be sure of its effectiveness [<xref rid="ref13" ref-type="bibr">13</xref>, <xref rid="ref15" ref-type="bibr">15</xref>]. This parameter varies from country to country and can be set in advance for a given country. Let <italic>&#x003c4;</italic><sub>0</sub> denotes the starting date of epidemic, <italic>&#x003c4;</italic><sub>1</sub> represents the date at which a government decides to apply the containment measures, <italic>&#x003c4;</italic><sub>2</sub> denotes the date at which a fraction <italic>p</italic> of the population is confined, <italic>&#x003c4;</italic><sub>3</sub> stands for the date at which the government decides to exit progressively the containment measures because either the restrictions take effect or there are budget or social limitations and <italic>&#x003c4;</italic><sub><italic>f</italic></sub> denotes the date for the end of the containment measures. Now, we divide the containment rate <italic>m</italic>(<italic>t</italic>) into four phases:</p><p><italic>Phase 0</italic>: period without containment measures (from date <italic>&#x003c4;</italic><sub>0</sub> to <italic>&#x003c4;</italic><sub>1</sub>), then <italic>m</italic>(<italic>t</italic>)&#x000a0;=&#x000a0;0.</p><p><italic>Phase 1</italic>: period when containment is taking place until the government reaches its maximum containment effort (from date <italic>&#x003c4;</italic><sub>1</sub> to <italic>&#x003c4;</italic><sub>2</sub>). In this phase we assume that the function <italic>m</italic> increases exponentially and reach the value <italic>p</italic> at date <italic>&#x003c4;</italic><sub>2</sub>. It follows that <italic>m</italic> takes the form <italic>m</italic>(<italic>t</italic>)&#x000a0;=&#x000a0;1&#x000a0;&#x02212;&#x000a0;exp (&#x000a0;&#x02212;&#x000a0;<italic>a</italic>(<italic>t</italic>&#x000a0;&#x02212;&#x000a0;<italic>&#x003c4;</italic><sub>1</sub>)) where <italic>a</italic>&#x000a0;=&#x000a0;&#x02212;ln(1&#x000a0;&#x02212;&#x000a0;<italic>p</italic>)/(<italic>&#x003c4;</italic><sub>2</sub>&#x000a0;&#x02212;&#x000a0;<italic>&#x003c4;</italic><sub>1</sub>).</p><p><italic>Phase 2</italic>: period where the maximum effort is maintained (from date <italic>&#x003c4;</italic><sub>3</sub> to <italic>&#x003c4;</italic><sub>4</sub>) and <italic>m</italic>(<italic>t</italic>)&#x000a0;=&#x000a0;<italic>p</italic>.</p><p><italic>Phase 3</italic>: period at which the government decides to relax the containment measures (from date <italic>&#x003c4;</italic><sub>3</sub> to <italic>&#x003c4;</italic><sub><italic>f</italic></sub>). This drop is linearly depending on the time so that the value of <italic>m</italic> at date <italic>&#x003c4;</italic><sub><italic>f</italic></sub> equals to 0. Then <italic>m</italic> is described as follows: <italic>m</italic>(<italic>t</italic>)&#x000a0;=&#x000a0;<italic>p</italic>&#x000a0;+&#x000a0;<italic>b</italic>(<italic>t</italic>&#x000a0;&#x02212;&#x000a0;<italic>&#x003c4;</italic><sub>3</sub>), where <italic>b</italic>&#x000a0;=&#x000a0;&#x02212;<italic>p</italic>/(<italic>&#x003c4;</italic><sub><italic>f</italic></sub>&#x000a0;&#x02212;&#x000a0;<italic>&#x003c4;</italic><sub>3</sub>).</p></sec><sec sec-type="other" id="sec5"><title>Model parameters</title><p>Before to go further, let us point out that in our paper, the values of the parameters <italic>f</italic>, <italic>&#x003c3;</italic>, <italic>&#x003bc;</italic>, <italic>&#x003b8;</italic>, <italic>&#x003c4;</italic><sub>0</sub>, <italic>&#x003c4;</italic><sub>3</sub>, <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, as well as the initial values <italic>S</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>S</italic><sub>c</sub>(<italic>&#x003c4;</italic><sub>0</sub>) and <italic>I</italic><sub>r</sub>(<italic>&#x003c4;</italic><sub>0</sub>) were chosen from expert opinions. The values of the parameters <italic>&#x003c4;</italic><sub>2</sub>, <italic>&#x003bb;</italic>, <italic>&#x000f1;</italic>, <italic>p</italic>, <italic>&#x003b2;</italic>, <italic>&#x003c3;</italic>, <italic>&#x003b7;</italic><sub>r</sub>, <italic>&#x003b7;</italic><sub>u</sub> as well as the initial values <italic>CI</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>Q</italic>(<italic>&#x003c4;</italic><sub>0</sub>) and <italic>E</italic>(<italic>&#x003c4;</italic><sub>0</sub>) were unknown. However, it is possible to identify them from specific time data. The value of the parameter <italic>q</italic> can be easily computed from current data. By setting <italic>x</italic>&#x000a0;=&#x000a0;(<italic>&#x003c4;</italic><sub>2</sub>, <italic>&#x003bb;</italic>, <italic>&#x000f1;</italic>, <italic>p</italic>, <italic>&#x003b2;</italic>, <italic>&#x003c3;</italic>, <italic>&#x003b7;</italic><sub>r</sub>, <italic>&#x003b7;</italic><sub>u</sub>, <italic>I</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>Q</italic>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>E</italic>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>&#x003c4;</italic><sub>2</sub>), we estimated an optimal value of <italic>x</italic> that fit with the data from France by minimising the following error function:<disp-formula id="eqn5"><label>5</label><graphic xlink:href="S0950268820002162_eqn5.jpg" mime-subtype="png" position="float" mimetype="image" orientation="portrait"/></disp-formula>where <italic>n</italic> is the number of observed data, obs(<italic>t</italic><sub><italic>l</italic></sub>) and sim(<italic>t</italic><sub><italic>l</italic></sub>, <italic>x</italic>) are the observed and calculated data at time <italic>t</italic><sub><italic>l</italic></sub> respectively.</p><sec id="sec5-1" sec-type="other"><title>Chosen values: f, &#x003c3;, &#x003bc;, &#x003b8;, &#x003c4;<sub>0</sub>, &#x003c4;<sub>3</sub>, &#x003c4;<sub><italic>f</italic></sub>, S<sub>u</sub>(&#x003c4;<sub>0</sub>), S<sub>c</sub>(&#x003c4;<sub>0</sub>) and I<sub>r</sub>(&#x003c4;<sub>0</sub>)</title><p><italic>Initial conditions</italic>: We started the simulations at the moment where in France, the number of reported cases were identified with 12 individuals, i.e. precisely on the date <italic>&#x003c4;</italic><sub>0</sub>&#x000a0;=&#x000a0;25 February. Then <italic>I</italic><sub>r</sub>(<italic>&#x003c4;</italic><sub>0</sub>)&#x000a0;=&#x000a0;12. The population of France is around 66&#x000a0;999&#x000a0;000 inhabitants [<xref rid="ref16" ref-type="bibr">16</xref>], thus, we set <italic>S</italic><sub>c</sub>(<italic>&#x003c4;</italic><sub>0</sub>)&#x000a0;=66&#x000a0;999&#x000a0;000. At that date, there were no confined individuals, thus <italic>S</italic><sub>c</sub>(<italic>&#x003c4;</italic><sub>0</sub>)&#x000a0;=&#x000a0;0.</p><p><italic>Value of parameter f</italic>: Recall that, (1&#x000a0;&#x02212;&#x000a0;<italic>f</italic>) stands for the fraction of exposed individuals that becomes unreported infectious and corresponds to the proportion of asymptomatic or silent carriers or mild infectious. (1&#x000a0;&#x02212;&#x000a0;<italic>f</italic>) ranges from 17.9% to 86% [<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref17" ref-type="bibr">17</xref>&#x02013;<xref rid="ref20" ref-type="bibr">20</xref>] and some reviews therein [<xref rid="ref21" ref-type="bibr">21</xref>]. The fractions of unreported individuals in these previous studies are derived from the number of tests performed. Therefore, the current fraction may be seriously underestimated. During the onset of COVID-19 in France, there were very little screening tests. That's why, we estimated that 1&#x000a0;&#x02212;&#x000a0;<italic>f</italic>&#x000a0;=&#x000a0;0.8 (i.e. <italic>f</italic>&#x000a0;=&#x000a0;0.2). Furthermore, we make it vary in the scenario 3 (effectiveness of the large-scale testing), as soon as the number of tests increases.</p><p><italic>Value of parameter &#x003c3;</italic>: The value of parameter <italic>&#x003c3;</italic> was calibrated to 0.2 so that <italic>&#x003c3;</italic>&#x000a0;=&#x000a0;<italic>f</italic>. In scenario 3, we assume that <italic>f</italic> increases in the same order as <italic>&#x003c3;</italic> when the time evolves (see <xref ref-type="fig" rid="fig02">Fig. 2(c)</xref>), because when the number of tests increases, the fraction of reported cases increases and thus the fraction <italic>&#x003c3;</italic> of susceptible unconfined individuals that is quarantined increases with contact tracing.
<fig id="fig02" fig-type="fig" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>Evolution over time of parameters <italic>m</italic>, <italic>&#x003c3;</italic>, <italic>f</italic>, <italic>&#x003b2;</italic><sub>r</sub>, <italic>&#x003b2;</italic><sub>u</sub> and <italic>&#x003c4;</italic><sub>3</sub> according to each scenario; the other parameters of the model are fixed as shown in <xref rid="tab01" ref-type="table">Table 1</xref>: (a) for scenario 1, only the parameter <italic>m</italic> is time dependent, <italic>f</italic>&#x000a0;=&#x000a0;<italic>&#x003c3;</italic>&#x000a0;=&#x000a0;0.2, <italic>&#x003b2;</italic><sub>r</sub>&#x000a0;=&#x000a0;0.846&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup>, <italic>&#x003b2;</italic><sub>u</sub>&#x000a0;=&#x000a0;2.115&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup> and <italic>&#x003c4;</italic><sub>3</sub>&#x000a0;= 11 May for all time. (b) For scenario 2, <italic>f</italic>&#x000a0;=&#x000a0;<italic>&#x003c3;</italic>&#x000a0;=&#x000a0;0.2, <italic>&#x003b2;</italic><sub>r</sub>&#x000a0;=&#x000a0;0.846&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup>, <italic>&#x003b2;</italic><sub>u</sub>&#x000a0;=&#x000a0;2.115&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup> for all time, only the parameter <italic>m</italic> is time dependent for three different values of the date at which the containment measures are relaxed, <italic>&#x003c4;</italic><sub>3</sub>, more precisely when <italic>&#x003c4;</italic><sub>3</sub> takes the values 11 May, 01 and 30 June. (c) For scenario 3, we set <italic>&#x003c4;</italic><sub>3</sub>&#x000a0;=May 11, <italic>m</italic>, <italic>f</italic> and <italic>&#x003c3;</italic> evolve over time, <italic>&#x003b2;</italic><sub>r</sub>&#x000a0;=&#x000a0;0.846&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup>, <italic>&#x003b2;</italic><sub>u</sub>&#x000a0;=&#x000a0;2.115&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup>. (d) For scenario 4, <italic>&#x003c4;</italic><sub>3</sub>&#x000a0;=11 May, <italic>f</italic>&#x000a0;=&#x000a0;<italic>&#x003c3;</italic>&#x000a0;=&#x000a0;0.2, &#x000a0;<italic>m</italic> evolves as in (a), in addition, the transmission rate <italic>&#x003b2;</italic><sub>r</sub> and <italic>&#x003b2;</italic><sub>u</sub> evolve. (e) For scenario 5, <italic>&#x003c4;</italic><sub>3</sub>&#x000a0;= 11 May, <italic>f</italic>, <italic>&#x003c3;</italic>, <italic>m</italic> evolve as in (c), moreover <italic>&#x003b2;</italic><sub>r</sub> and <italic>&#x003b2;</italic><sub>u</sub> evolve as in (d).</p></caption><graphic xlink:href="S0950268820002162_fig2"/></fig>
<table-wrap id="tab01" orientation="portrait" position="float"><label>Table 1.</label><caption><p>List of parameters and their meaning and the parameter ranges for which the model was solved</p></caption><alternatives><graphic xlink:href="S0950268820002162_tab1"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" colspan="1" rowspan="1">Name</th><th align="center" colspan="1" rowspan="1">Meaning</th><th align="center" colspan="1" rowspan="1">Value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><italic>p</italic></td><td colspan="1" rowspan="1">Maximum fraction of the susceptible that a government can confine</td><td colspan="1" rowspan="1">0.93</td></tr><tr><td colspan="1" rowspan="1"><italic>f</italic></td><td colspan="1" rowspan="1">Fraction of Exposed that becomes reported infectious</td><td colspan="1" rowspan="1">0.4</td></tr><tr><td colspan="1" rowspan="1"><italic>&#x000f1;</italic></td><td colspan="1" rowspan="1">Infectivity of reported individuals</td><td colspan="1" rowspan="1">0.5</td></tr><tr><td colspan="1" rowspan="1"><italic>&#x003bb;</italic></td><td colspan="1" rowspan="1">Fraction of quarantined individuals that becomes infectious</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1"><italic>q</italic></td><td colspan="1" rowspan="1">Fraction of reported individuals that becomes recovered</td><td colspan="1" rowspan="1">0.83</td></tr><tr><td colspan="1" rowspan="1"><italic>&#x003c3;</italic></td><td colspan="1" rowspan="1">Fraction of individuals which is quarantined with contact tracing</td><td colspan="1" rowspan="1">0.2</td></tr><tr><td colspan="1" rowspan="1"><italic>&#x003b2;</italic><sub>r</sub>&#x000a0;=&#x000a0;<italic>&#x000f1;&#x003b2;</italic></td><td colspan="1" rowspan="1">Transmission rate of reported individuals</td><td colspan="1" rowspan="1">0.846&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup></td></tr><tr><td colspan="1" rowspan="1"><italic>&#x003b2;</italic><sub>u</sub>&#x000a0;=&#x000a0;<italic>&#x003b2;</italic></td><td colspan="1" rowspan="1">Transmission rate of unreported individuals</td><td colspan="1" rowspan="1">2.115&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup></td></tr><tr><td colspan="1" rowspan="1">(1&#x000a0;&#x02212;&#x000a0;<italic>q</italic>)<italic>&#x003b7;</italic><sub>r</sub></td><td colspan="1" rowspan="1">Disease-induced death rate of reported individuals</td><td colspan="1" rowspan="1">0.016</td></tr><tr><td colspan="1" rowspan="1">1/<italic>&#x003bc;</italic></td><td colspan="1" rowspan="1">Average length of the exposed period</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1/<italic>&#x003b7;</italic><sub>r</sub></td><td colspan="1" rowspan="1">Average length of infectious period of reported individuals</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1/<italic>&#x003b7;</italic><sub>u</sub></td><td colspan="1" rowspan="1">Average length of infectious period of unreported individuals</td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">1/<italic>&#x003b8;</italic></td><td colspan="1" rowspan="1">Average length of the quarantine period</td><td colspan="1" rowspan="1">14</td></tr><tr><td colspan="1" rowspan="1"><italic>m</italic>(<italic>t</italic>)</td><td colspan="1" rowspan="1">The fraction of confined susceptible at any time <italic>t</italic></td><td colspan="1" rowspan="1">[0&#x000a0;&#x02212;&#x000a0;<italic>p</italic>], see <xref ref-type="fig" rid="fig02">Figure 2</xref></td></tr><tr><td colspan="1" rowspan="1"><italic>&#x003c4;</italic><sub>0</sub></td><td colspan="1" rowspan="1">Starting date of the epidemic</td><td colspan="1" rowspan="1">25 February</td></tr><tr><td colspan="1" rowspan="1"><italic>&#x003c4;</italic><sub>1</sub></td><td colspan="1" rowspan="1">Starting date of the containment</td><td colspan="1" rowspan="1">17 March</td></tr><tr><td colspan="1" rowspan="1"><italic>&#x003c4;</italic><sub>2</sub></td><td colspan="1" rowspan="1">Date at which a fraction <italic>p</italic> of the population is confined</td><td colspan="1" rowspan="1">12 April</td></tr><tr><td colspan="1" rowspan="1"><italic>&#x003c4;</italic><sub>3</sub></td><td colspan="1" rowspan="1">Decision date of relaxation of the containment measures</td><td colspan="1" rowspan="1">11 May&#x02013;28 June</td></tr><tr><td colspan="1" rowspan="1"><italic>&#x003c4;</italic><sub><italic>f</italic></sub></td><td colspan="1" rowspan="1">End date of containment measures</td><td colspan="1" rowspan="1">01 September</td></tr><tr><td colspan="1" rowspan="1">Initial values</td><td colspan="1" rowspan="1">Meaning</td><td colspan="1" rowspan="1">Value</td></tr><tr><td colspan="1" rowspan="1"><italic>S</italic><sub>c</sub>(<italic>&#x003c4;</italic><sub>0</sub>)</td><td colspan="1" rowspan="1">Initial confined susceptible population</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1"><italic>S</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>)</td><td colspan="1" rowspan="1">Initial unconfined susceptible population</td><td colspan="1" rowspan="1"> 66&#x000a0;990&#x000a0;000</td></tr><tr><td colspan="1" rowspan="1"><italic>E</italic>(<italic>&#x003c4;</italic><sub>0</sub>)</td><td colspan="1" rowspan="1">Initial exposed population</td><td colspan="1" rowspan="1">112</td></tr><tr><td colspan="1" rowspan="1"><italic>I</italic><sub>r</sub>(<italic>&#x003c4;</italic><sub>0</sub>)</td><td colspan="1" rowspan="1">Initial reported population</td><td colspan="1" rowspan="1">12</td></tr><tr><td colspan="1" rowspan="1"><italic>I</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>)</td><td colspan="1" rowspan="1">Initial unreported population</td><td colspan="1" rowspan="1">50</td></tr><tr><td colspan="1" rowspan="1"><italic>R</italic>(<italic>&#x003c4;</italic><sub>0</sub>)</td><td colspan="1" rowspan="1">Initial recovered population</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1"><italic>Q</italic>(<italic>&#x003c4;</italic><sub>0</sub>)</td><td colspan="1" rowspan="1">Initial quarantined population</td><td colspan="1" rowspan="1">36</td></tr></tbody></table></alternatives></table-wrap></p><p><italic>Value of parameter &#x003c4;</italic><sub>1</sub>: The starting date of the containment was fixed on 17 March, then <italic>&#x003c4;</italic><sub>1</sub>&#x000a0;=&#x000a0;17 March.</p><p><italic>Value of parameter &#x003c4;</italic><sub>3</sub>: According to the announcement of French government of 13 April, a gradual deconfinement started on 11 May. So for model validation, we fixed <italic>&#x003c4;</italic><sub>3</sub>&#x000a0;=&#x000a0;11 May.</p><p><italic>Value of parameter &#x003c4;</italic><sub><italic>f</italic></sub>: We fixed the end date of containment measures on 1 September.</p><p><italic>Value of parameter &#x003bc;</italic>: The mean incubation period 1/<italic>&#x003bc;</italic> was fixed to 5 days see [<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref22" ref-type="bibr">22</xref>, <xref rid="ref23" ref-type="bibr">23</xref>].</p><p><italic>Value of parameter &#x003b8;</italic>: We considered 14 days to isolate the quarantined individuals, therefore, 1/<italic>&#x003b8;</italic>&#x000a0;=&#x000a0;14 days.</p></sec><sec id="sec5-2" sec-type="other"><title>Estimated values: &#x003c4;<sub>2</sub>, &#x003bb;, &#x000f1;, p, &#x003b2;, &#x003c3;, &#x003b7;<sub>r</sub>, &#x003b7;<sub>u</sub>, I<sub>u</sub>(&#x003c4;<sub>0</sub>), Q(&#x003c4;<sub>0</sub>), E(&#x003c4;<sub>0</sub>), &#x003c4;<sub>2</sub> and q</title><p>By calibrating the model with the data corresponding to the cumulated reported cases for France, we identified some values of model parameters giving a good fit of the observed data obtained in [<xref rid="ref24" ref-type="bibr">24</xref>]. The parameter values and initial conditions estimated are listed in <xref rid="tab01" ref-type="table">Table 1</xref>.</p><p><italic>Value of parameters &#x003c4;</italic><sub>2</sub>
<italic>and p</italic>: We estimate that the government has successfully confined 93% of the population on the date 12 April, thus, <italic>&#x003c4;</italic><sub>2</sub>&#x000a0;=&#x000a0;12 April and <italic>p</italic>&#x000a0;=&#x000a0;0.93. This value means that 93% of the population was confined on date <italic>&#x003c4;</italic><sub>2</sub> equals to 12 April, thus <italic>S</italic><sub>c</sub>(<italic>&#x003c4;</italic><sub>2</sub>)&#x000a0;=&#x000a0;62&#x000a0;300&#x000a0;700. In this case, 7% of the population that remained active and we set <italic>S</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>2</sub>)&#x000a0;=&#x000a0;4&#x000a0;689&#x000a0;300. Note that this number corresponds to approximately 15.78% of active population in France which was 29&#x000a0;700&#x000a0;000 according to INSEE in 2017 [<xref rid="ref25" ref-type="bibr">25</xref>].</p><p><italic>Value of parameters &#x003b7;</italic><sub>r</sub>
<italic>and &#x003b7;</italic><sub>u</sub>: By fitting with data from France, we estimate that the mean duration of infectious period for unreported individuals, 1/<italic>&#x003b7;</italic><sub>u</sub>&#x000a0;=&#x000a0;4 days and for reported ones, 1/<italic>&#x003b7;</italic><sub>r</sub>&#x000a0;=&#x000a0;10 days.</p><p><italic>Value of parameters &#x003b2;</italic><sub>r</sub>, <italic>&#x003b2;</italic><sub>u</sub>
<italic>and &#x000f1;</italic>: We estimated that the infectivity of reported cases <italic>&#x000f1;</italic> equals to 0.40 compared to infectivity of unreported which is 1. The transmission rate <italic>&#x003b2;</italic><sub>u</sub>&#x000a0;=&#x000a0;<italic>&#x003b2;</italic> of unreported individuals is estimated to 2.115&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup>/day, then the transmission rate of reported individuals equals to <italic>&#x003b2;</italic><sub>r</sub>&#x000a0;=&#x000a0;<italic>&#x003b2;&#x000f1;</italic>&#x000a0;=&#x000a0;0.846&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup>/day.</p><p><italic>Value of parameter q</italic>: Since 1&#x000a0;&#x02212;&#x000a0;<italic>q</italic> represents the fraction of reported individuals that dies, thus <inline-formula><inline-graphic xlink:href="S0950268820002162_inline12.jpg" mime-subtype="png" mimetype="image"/></inline-formula></p><p>From current data (31 July), we find 1&#x000a0;&#x02212;&#x000a0;<italic>q</italic>&#x000a0;=&#x000a0;30&#x000a0;254/186&#x000a0;573&#x000a0;=&#x000a0;0.1622. It follows that the disease-induced death rate of reported individuals, (1&#x000a0;&#x02212;&#x000a0;<italic>q</italic>)<italic>&#x003b7;</italic><sub>r</sub>, equals to 0.1622&#x000a0;&#x000d7;&#x000a0;1/10&#x000a0;=&#x000a0;0.0162/day. Furthermore, the fraction of reported individuals that becomes recovered equals to <italic>q</italic>&#x000a0;=&#x000a0;0.8378.</p><p><italic>Value of parameters E</italic>(<italic>&#x003c4;</italic><sub>0</sub>), <italic>Q</italic>(<italic>&#x003c4;</italic><sub>0</sub>) <italic>and I</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>): We estimate that at date <italic>&#x003c4;</italic><sub>0</sub>, we have <italic>Q</italic>(<italic>&#x003c4;</italic><sub>0</sub>)&#x000a0;=&#x000a0;36, <italic>I</italic><sub>u</sub>(<italic>&#x003c4;</italic><sub>0</sub>)&#x000a0;=&#x000a0;50 and <italic>E</italic>(<italic>&#x003c4;</italic><sub>0</sub>)&#x000a0;=&#x000a0;112.</p></sec></sec><sec sec-type="other" id="sec6"><title>Simulation experiments: application to data from France</title><sec id="sec6-1" sec-type="other"><title>Scenario 1: validation of model with data from France</title><p>We selected for model validation, the data obtained for daily reported (DRI<sub>r</sub>) and cumulative reported (CRI<sub>r</sub>) cases for France see [<xref rid="ref24" ref-type="bibr">24</xref>]. Some constants and parameters involved in the model are listed in <xref rid="tab01" ref-type="table">Table 1</xref>. The results of this scenario are illustrated in <xref ref-type="fig" rid="fig03">Figure 3</xref>.
<fig id="fig03" fig-type="fig" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p>Scenario 1: Validation of model with currently data from France. The date at which the containment measures are relaxed, <italic>&#x003c4;</italic><sub>3</sub>, was fixed to 11 May; the end date of containment measures, <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, was fixed to 1 September. (a) The cumulative number of reported CI<sub>r</sub> and unreported CI<sub>u</sub> cases simulated, and observed data CIrData. (b) The daily number of reported DI<sub>r</sub> and unreported DI<sub>u</sub> cases from the model and observed data DDataI<sub>r</sub>. (c) The confined and unconfined susceptible <italic>S</italic><sub>c</sub> and <italic>S</italic><sub>u</sub>. (d) The daily reproductive number <inline-formula><inline-graphic xlink:href="S0950268820002162_inline35.jpg" mime-subtype="png" mimetype="image"/></inline-formula>. In this scenario, the values of the parameters were estimated and listed in <xref rid="tab01" ref-type="table">Table 1</xref> except for the containment function <italic>m</italic> which varies between 0 and 1 (see <xref ref-type="fig" rid="fig02">Fig. 2(a)</xref>).</p></caption><graphic xlink:href="S0950268820002162_fig3"/></fig></p></sec><sec id="sec6-2" sec-type="other"><title>Scenario 2: effectiveness of containment measures</title><p>The objective of this scenario is to analyse if the outbreak might stop for different values of the date at which the containment measures are relaxed, namely <italic>&#x003c4;</italic><sub>3</sub>. Then, the value of the latter is assumed varying from 11 May, 1 and 30 June. The end date of containment measures <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, is fixed to 1 September. The values of the parameters used are listed in <xref rid="tab01" ref-type="table">Table 1</xref> except for the containment function <italic>m</italic> that varies (see <xref ref-type="fig" rid="fig02">Fig. 2(b)</xref>).</p><p>The results of this scenario are illustrated in <xref ref-type="fig" rid="fig04">Figure 4</xref>.
<fig id="fig04" fig-type="fig" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p>Scenario 2: Longer-term forecasting of epidemic spreading according to different values of the date at which the containment measures are relaxed, <italic>&#x003c4;</italic><sub>3</sub> that varies between 11 May and 01 and 30 June. The end date of containment measures <italic>&#x003c4;</italic><sub><italic>f</italic></sub> was fixed to 1 September. (a) The cumulative number of reported CI<sub>r</sub> cases simulated. (b) The daily number of reported DI<sub>r</sub> cases from the model. (c) The number of confined susceptible <italic>S</italic><sub>c</sub>. (d) The daily (effective) reproductive number <inline-formula><inline-graphic xlink:href="S0950268820002162_inline36.jpg" mime-subtype="png" mimetype="image"/></inline-formula>. In this scenario, the values of the parameters were estimated and listed in <xref rid="tab01" ref-type="table">Table 1</xref> except for the containment function <italic>m</italic> which varies between 0 and 1 for different values of <italic>&#x003c4;</italic><sub>3</sub> (see <xref ref-type="fig" rid="fig02">Fig. 2(b)</xref>).</p></caption><graphic xlink:href="S0950268820002162_fig4"/></fig></p></sec><sec id="sec6-3" sec-type="other"><title>Scenario 3: effectiveness of the large-scale testing</title><p>To investigate the effectiveness of the large-scale test of detection of infected individuals, the date at which the containment measures are relaxed, <italic>&#x003c4;</italic><sub>3</sub>, is fixed to 11 May; the end date of containment measures, <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, is fixed to 1 September. We assume that between the dates <italic>&#x003c4;</italic><sub>3</sub> and <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, the fraction of reported cases <italic>f</italic> increases linearly and reach 200% of its initial value and the fraction of susceptible individuals which is quarantined <italic>&#x003c3;</italic> is also increased linearly to reach 200% of its initial value (see <xref ref-type="fig" rid="fig02">Fig. 2(c)</xref>), the initial values is estimated in scenario 1. The values of the other parameters are listed in <xref rid="tab01" ref-type="table">Table 1</xref> except for the containment function <italic>m</italic> that varies (see <xref ref-type="fig" rid="fig02">Fig. 2(b)</xref>).</p><p>The results of this scenario are illustrated in <xref ref-type="fig" rid="fig05">Figure 5</xref>.
<fig id="fig05" fig-type="fig" orientation="portrait" position="float"><label>Fig. 5.</label><caption><p>Scenario 3: Longer-term forecasting of epidemic spreading in case of large-scale tests of detection on infected individuals. <italic>&#x003c4;</italic><sub>3</sub> was fixed to 11 May; <italic>&#x003c4;</italic><sub><italic>f</italic></sub> was fixed to 01 September. Between the dates <italic>&#x003c4;</italic><sub>3</sub> and <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, the parameter <italic>f</italic> was assumed to increase linearly to reach 200% of its initial value, <italic>&#x003c3;</italic> increased linearly to reach 200% of its initial value (see <xref ref-type="fig" rid="fig02">Fig. 2(c)</xref>). The values of the other parameters are listed in <xref rid="tab01" ref-type="table">Table 1</xref> except for <italic>m</italic> that varies (see <xref ref-type="fig" rid="fig02">Fig. 2(b)</xref>). (a) The cumulative number of simulated reported CI<sub>r</sub> and unreported CI<sub>u</sub> cases and observed data CIrData. (b) The daily number of simulated reported DI<sub>r</sub> and unreported DI<sub>u</sub> cases and observed data DDataI<sub>r</sub>. (c) The number of simulated confined and unconfined susceptible <italic>S</italic><sub>c</sub> and <italic>S</italic><sub>u</sub>. (d) The daily reproductive number <inline-formula><inline-graphic xlink:href="S0950268820002162_inline37.jpg" mime-subtype="png" mimetype="image"/></inline-formula>.</p></caption><graphic xlink:href="S0950268820002162_fig5"/></fig></p></sec><sec id="sec6-4" sec-type="other"><title>Scenario 4: social distancing and/or wearing masks measures</title><p>To study the social distancing and/or wearing masks measures, the date at which the containment measures are relaxed, <italic>&#x003c4;</italic><sub>3</sub>, was fixed to 11 May; the end date of containment measures, <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, is fixed to 1 September. We assume that between the dates <italic>&#x003c4;</italic><sub>3</sub>, and <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, the transmission rate <italic>&#x003b2;</italic> decreases linearly to reach 75% of its initial value (see <xref ref-type="fig" rid="fig02">Fig. 2(d)</xref>). The values of the other parameters are listed in <xref rid="tab01" ref-type="table">Table 1</xref> except for the containment function <italic>m</italic> that varies (see <xref ref-type="fig" rid="fig02">Fig. 2(b)</xref>).</p><p>The results of this scenario are illustrated in <xref ref-type="fig" rid="fig06">Figure 6</xref>.
<fig id="fig06" fig-type="fig" orientation="portrait" position="float"><label>Fig. 6.</label><caption><p>Scenario 4: Longer-term forecasting of epidemic spreading in case of the social distancing and wearing masks measures. <italic>&#x003c4;</italic><sub>3</sub> was fixed to 11 May; <italic>&#x003c4;</italic><sub><italic>f</italic></sub> was fixed to 01 September. Between the dates <italic>&#x003c4;</italic><sub>3</sub> and <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, the parameter <italic>&#x003b2;</italic> decreases of 75% of its initial value (see <xref ref-type="fig" rid="fig02">Fig. 2(d)</xref>). The values of the other parameters are listed in <xref rid="tab01" ref-type="table">Table 1</xref> except for <italic>m</italic> that varies (see <xref ref-type="fig" rid="fig02">Fig. 2(b)</xref>). (a) The cumulative number of simulated reported CI<sub>r</sub> and unreported CI<sub>u</sub> cases and observed data CIrData. (b) The daily number of simulated reported DI<sub>r</sub> and unreported DI<sub>u</sub> cases and observed data DDataI<sub>r</sub>. (c) The number of simulated confined and unconfined susceptible <italic>S</italic><sub>c</sub> and <italic>S</italic><sub>u</sub>. (d) The daily reproductive number <inline-formula><inline-graphic xlink:href="S0950268820002162_inline38.jpg" mime-subtype="png" mimetype="image"/></inline-formula>.</p></caption><graphic xlink:href="S0950268820002162_fig6"/></fig></p></sec><sec id="sec6-5" sec-type="other"><title>Scenario 5: combined effects of large-scale testing and social distancing measures</title><p>To test the combined effects of large-scale testing and social distancing social and/or wearing masks measures, we combine the conditions of scenarios 1 and 2. The date at which the containment measures are relaxed, <italic>&#x003c4;</italic><sub>3</sub>, is fixed to 11 May; the end date of containment measures, <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, is fixed to 1 September. Between the dates <italic>&#x003c4;</italic><sub>3</sub> and <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, we assume that <italic>f</italic> increases linearly to reach 200% of its initial value, <italic>&#x003c3;</italic> increases linearly to reach 200% of its initial value and <italic>&#x003b2;</italic> decreases of 75% of its initial value see <xref ref-type="fig" rid="fig02">Figure 2(d)</xref> for these different variations of parameter values.</p><p>The results of this scenario are illustrated in <xref ref-type="fig" rid="fig07">Figure 7</xref>.
<fig id="fig07" fig-type="fig" orientation="portrait" position="float"><label>Fig. 7.</label><caption><p>Scenario 5: Longer-term forecasting of epidemic spreading in case of both social distancing and/or wearing masks and large-scale tests. <italic>&#x003c4;</italic><sub>3</sub> was fixed to 11 May; <italic>&#x003c4;</italic><sub><italic>f</italic></sub> was fixed to 1 September. Between the dates <italic>&#x003c4;</italic><sub>3</sub> and <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, the parameter <italic>f</italic> increases linearly to reach 200% of its initial value, <italic>&#x003c3;</italic> increases linearly to reach 200% of its initial value (see <xref ref-type="fig" rid="fig02">Fig. 2(c)</xref>). <italic>&#x003b2;</italic> decreases to 75% of its initial value (see <xref ref-type="fig" rid="fig02">Fig. 2(d)</xref>). The values of the other parameters are listed in <xref rid="tab01" ref-type="table">Table 1</xref> except for <italic>m</italic> that varies (see <xref ref-type="fig" rid="fig02">Fig. 2(b)</xref>). (a) The cumulative number of simulated reported CI<sub>r</sub> and unreported CI<sub>u</sub> cases and observed data CIrData. (b) The daily number of simulated reported DI<sub>r</sub> and unreported DI<sub>u</sub> cases and observed data DDataI<sub>r</sub>. (c) The number of simulated confined and unconfined susceptible <italic>S</italic><sub>c</sub> and <italic>S</italic><sub>u</sub>. (d) The daily reproductive number <inline-formula><inline-graphic xlink:href="S0950268820002162_inline39.jpg" mime-subtype="png" mimetype="image"/></inline-formula>.</p></caption><graphic xlink:href="S0950268820002162_fig7"/></fig></p></sec></sec><sec sec-type="discussion" id="sec7"><title>Discussion and conclusion</title><p>This model takes into account the measures of confinement, distinguishing between confined individuals, quarantined individuals and isolated individuals. Many values were estimated to fit the beginning of expansion of disease in France, other were inferred from expert opinions, see Section &#x02018;Model parameters&#x02019;. The proportion (1&#x000a0;&#x02212;&#x000a0;<italic>f</italic>) ranges from 17.9% to 86% [<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref17" ref-type="bibr">17</xref>&#x02013;<xref rid="ref20" ref-type="bibr">20</xref>] and some reviews therein [<xref rid="ref21" ref-type="bibr">21</xref>]. The lower value was observed on board of the Diamond princess, i.e. in conditions which are not representative of large-scale populations living in larger surfaces. On the other hand, in [<xref rid="ref26" ref-type="bibr">26</xref>] and in a WHO report, it was estimated that between 80% and 86% of all infections were undocumented. Since this fraction is dependent on the number of tests performed and since during the onset of COVID-19 in France, there were fewer screening tests, we eventually chose <italic>f</italic>&#x000a0;=&#x000a0;0.2.</p><p>As for <italic>f</italic>, the mean duration of infectious period is a debatable point. In [<xref rid="ref27" ref-type="bibr">27</xref>], the authors estimate that the asymptomatic individuals had median virus persistence duration of 8.87 days (95% confidence interval 7.65&#x02013;10.27). This duration varies also between asymptomatic and symptomatic individuals [<xref rid="ref28" ref-type="bibr">28</xref>], even when mildly affected. By contrast, all severe cases were still tested positive at or beyond day 10 post-onset [<xref rid="ref29" ref-type="bibr">29</xref>]. This longer virus persistence in severe cases as compared to milder cases has been also demonstrated by [<xref rid="ref30" ref-type="bibr">30</xref>] but not by all authors, see some reviews therein [<xref rid="ref21" ref-type="bibr">21</xref>]. Note also that in the literature, the estimate of the mean duration of infectious period of reported individuals is not always clear, since some authors include hospitalisation or isolation period, others do not. Results vary between 2 and 8 days [<xref rid="ref26" ref-type="bibr">26</xref>, <xref rid="ref31" ref-type="bibr">31</xref>, <xref rid="ref32" ref-type="bibr">32</xref>]. Our model implicitly takes into account a combined effect of duration of infectivity and viral load, which results in risk of transmission. Indeed, the mean duration of infectious period estimated to be 10 days for reported individuals is coherent with the estimation in [<xref rid="ref33" ref-type="bibr">33</xref>] based on clinical, microbiologic, epidemiologic and clinical data. Since we estimate the infectivity of the reported cases to be equal to 0.4, that of unreported cases in term of duration of infectious period, it means that reported individuals are infectious for 40% of their infectious period, i.e. 4 days. If the infectivity is interpreted in terms of viral load, it means that 40% of the viral load excreted by the infectious reported cases is infective. Such a link between duration of infectious period and infectivity (i.e. interpreted in terms of viral load) also holds in the literature except in [<xref rid="ref34" ref-type="bibr">34</xref>] where the authors observed no difference in viral load between asymptomatic and symptomatic patients. In [<xref rid="ref35" ref-type="bibr">35</xref>] the virus level in the asymptomatic group was significantly lower than that in the symptomatic group in the acute phase.</p><p><xref ref-type="fig" rid="fig03">Figure 3</xref> shows the adequacy of the model for predicting the evolution of number of cases in the beginning of the crisis until end of June. It also shows that as soon as confinement is reduced or stopped, the daily reproduction number <inline-formula><inline-graphic xlink:href="S0950268820002162_inline13.jpg" mime-subtype="png" mimetype="image"/></inline-formula> value increases again and a new wave of epidemics is to be expected as soon as its value is higher than 1. As observed in <xref ref-type="fig" rid="fig04">Figure 4</xref> (for longer-term forecasting), such waves are expected to appear very shortly after reduction of confinement, once the incubation period is spent. These values will allow predicting the effectiveness of the containment measures as well as risk and the intensity of possible resurgences of the new waves of epidemic in France. Indeed, the measures of confinement have a strong impact on the value of the daily reproduction number <inline-formula><inline-graphic xlink:href="S0950268820002162_inline14.jpg" mime-subtype="png" mimetype="image"/></inline-formula>
<xref ref-type="fig" rid="fig04">Figure 4</xref> shows that, while it was equal to nearly 5 in the beginning of the disease, before confinement, it decreased to about 0.5 as long as confinement of most people takes place and increased to a lower value, between 2 and 2.5, that is about half its former value. But even if its value is reduced, it remains higher than 1. It is also to note that, unexpectedly, its value was lower when end of confinement was earlier. <xref ref-type="fig" rid="fig03">Figures 3</xref> and <xref ref-type="fig" rid="fig04">4</xref> show that the current increase in the number of cases could be expected as soon as containment was relaxed from mid-May to September. However, the number of cases are expected to decrease if a higher proportion of infected people are detected and confined, which is currently the case. Delaying the very starting date of deconfinement to 30 June would have resulted in a later and higher wave but not as late as could be expected for a starting date to 11 May. All French people are expected to be either reported or unreported infected individuals at the end of 2020, i.e. before expected development of vaccines. However, some of those values may change with evolution of measures of prevention such as social distancing and/or wearing masks, large-scale testing, treatment of the disease.</p><p><italic>Social distancing and wearing masks measures</italic> directly influence the transmission rate which is expected to dramatically decrease with the increasing tendency to wear masks. Its effect was investigated in scenario 3 where the transmission rate was assumed to decrease linearly to reach the value 75% of its initial one as shown in <xref ref-type="fig" rid="fig02">Figure 2(d)</xref>. The results of this scenario are shown in <xref ref-type="fig" rid="fig05">Figure 5</xref>. The transmission rate may be dramatically decreased. But the results show that this measure alone is insufficient to eliminate the disease.</p><p>The effectiveness of the <italic>large-scale test of detection</italic> of infected individuals was analysed and shown in <xref ref-type="fig" rid="fig06">Figure 6</xref>. The fraction of reported cases, from date <italic>&#x003c4;</italic><sub>3</sub> to <italic>&#x003c4;</italic><sub><italic>f</italic></sub>, the fraction of reported cases <italic>f</italic> was assumed increase linearly to reach the value 200% of its initial one and the fraction of susceptible individuals which is quarantined <italic>&#x003c3;</italic> was also increased linearly to reach the value 200% of its initial one (see <xref ref-type="fig" rid="fig02">Figs 2(b)</xref> and <xref ref-type="fig" rid="fig02">(c)</xref>). These values may be observed by tracking all former contacts of any newly reported case, and systematically testing them. As in the former scenario dates of relaxation and end of containment measures were fixed to 11 May and 1 September respectively. Results show that this measure without further action is also insufficient to control the outbreak.</p><p>The <italic>combined measures</italic> of large-scale testing and social distancing and/or wearing masks measures was studied in scenario 5. The transmission rates (reported and unreported individuals) were assumed to decrease from 75% to date <italic>&#x003c4;</italic><sub>2</sub> to <italic>&#x003c4;</italic><sub><italic>f</italic></sub> (see <xref ref-type="fig" rid="fig02">Fig. 2(d)</xref>). <xref ref-type="fig" rid="fig07">Figure 7</xref> shows the effectiveness of these combined measures and the potential of such a strategy. In particular, it shows that predicted data are compatible with the current situation with no evidence yet of a second wave. This result also shows that protective measures must be maintained for a long term before the hypothesis of a second wave may be discarded.</p><p>In the absence of any control measure, the basic reproduction number <inline-formula><inline-graphic xlink:href="S0950268820002162_inline15.jpg" mime-subtype="png" mimetype="image"/></inline-formula> is equal to 4.8739. Most of this value is due to the weight of transmission by unreported individuals <inline-formula><inline-graphic xlink:href="S0950268820002162_inline16.jpg" mime-subtype="png" mimetype="image"/></inline-formula> and the weight of transmission by reported cases accounts for much less <inline-formula><inline-graphic xlink:href="S0950268820002162_inline17.jpg" mime-subtype="png" mimetype="image"/></inline-formula>. These values show that the major number of secondary infections is produced by the unreported individuals. With increasing use of appropriate tests, reported individuals will be more precisely diagnosed, thus the fraction of reported cases <italic>f</italic> will increase and thus the importance of <inline-formula><inline-graphic xlink:href="S0950268820002162_inline18.jpg" mime-subtype="png" mimetype="image"/></inline-formula> in the total value of <inline-formula><inline-graphic xlink:href="S0950268820002162_inline19.jpg" mime-subtype="png" mimetype="image"/></inline-formula>. Since the infectivity of reported individuals was estimated at 0.4 compared to infectivity of unreported the increase in <inline-formula><inline-graphic xlink:href="S0950268820002162_inline20.jpg" mime-subtype="png" mimetype="image"/></inline-formula> will be very small showing the importance of detecting infectious individuals; the evolution over time of the effective reproductive number <inline-formula><inline-graphic xlink:href="S0950268820002162_inline21.jpg" mime-subtype="png" mimetype="image"/></inline-formula> and effective weight of transmission <inline-formula><inline-graphic xlink:href="S0950268820002162_inline22.jpg" mime-subtype="png" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="S0950268820002162_inline23.jpg" mime-subtype="png" mimetype="image"/></inline-formula> are shown in <xref ref-type="fig" rid="fig07">Figure 7(d)</xref>. Therefore, the reported individuals will have a lower propensity to transmit the virus. Through stronger measures of prevention, the probability of contaminating other people will be lower.</p><p>With the confinement measures, the minimal percentage (critical fraction) of susceptible individuals that should be confined to eliminate the COVID-19 equals to <inline-formula><inline-graphic xlink:href="S0950268820002162_inline24.jpg" mime-subtype="png" mimetype="image"/></inline-formula> (see for instance [<xref rid="ref13" ref-type="bibr">13</xref>, <xref rid="ref15" ref-type="bibr">15</xref>]). By confining more susceptible individuals, we increase the kinetics of elimination of the disease. By fitting the model with the French data, we estimated this fraction to <italic>p</italic>&#x000a0;=&#x000a0;93%. This value belongs to the critical interval, namely <inline-formula><inline-graphic xlink:href="S0950268820002162_inline25.jpg" mime-subtype="png" mimetype="image"/></inline-formula></p><p>By analysing the results of simulations, we can conclude that the containment measures appear to have slowed the growth of the COVID-19 outbreak. Our model predicts that a second big wave of the epidemic may not be avoided if the situation remains unchanged and if the French government does not maintain the current efforts on large-scale tests, obligation of wearing masks inside and in some cases outside and other prophylactic measures. However, it also shows that these measures are efficient to avoid such a risk, thus preserving public health and avoiding a new confinement and all its terrible consequences, see <xref ref-type="fig" rid="fig03">Figures 3</xref> and <xref ref-type="fig" rid="fig04">4</xref>. While if no measures were implemented, even only one infected individual in the population would result in a new wave of infections and a new period of confinement. Some obligations will succeed in avoiding a second wave of COVID-19.</p><p>In this paper, we formulated a new model to describe the spread of COVID-19 to understand the effectiveness of the containment and quarantine measures. It is able to reproduce observed data from France and probably other countries.</p></sec></body><back><ack><title>Acknowledgement</title><p>The authors would like to thank two anonymous referees for many helpful suggestions.</p></ack><sec id="nts1" sec-type="COI-statement"><title>Conflict of interest</title><p>None.</p></sec><sec id="sec-das" sec-type="data-availability"><title>Data availability statement</title><p>The datasets generated during the current study are graphical represented in the scenarios 1-5. The datasets from France used to fit the model during the current study are freely available via online public domains [<xref rid="ref25" ref-type="bibr">25</xref>].</p></sec><ref-list id="reflist1"><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="other" id="cite1"><collab>World Health Organization</collab> (<year>2019</year>) Report of the WHO-China Joint Mission on Coronavirus Disease, pp. <fpage>16</fpage>&#x02013;<lpage>24</lpage>. Available at <uri xlink:href="https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf">https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf</uri> (Accessed <date-in-citation content-type="access-date">05 May 2020</date-in-citation>).</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal" id="cite2"><string-name><surname>Arino</surname>
<given-names>J</given-names></string-name> and <string-name><surname>Portet</surname>
<given-names>S</given-names></string-name> (<year>2020</year>) <article-title>A simple model for COVID-19</article-title>. <source>Infectious Disease Modelling</source>
<volume>5</volume>, <fpage>309</fpage>&#x02013;<lpage>315</lpage>.<pub-id pub-id-type="pmid">32346663</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal" id="cite3"><string-name><surname>Fanelli</surname>
<given-names>D</given-names></string-name> and <string-name><surname>Piazza</surname>
<given-names>F</given-names></string-name> (<year>2020</year>) <article-title>Analysis and forecast of COVID-19 spreading in China, Italy and France</article-title>. <source>Chaos Solitons and Fractals</source>
<volume>134</volume>, <fpage>109761</fpage>.</mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal" id="cite4"><string-name><surname>Liu</surname>
<given-names>Z</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Understanding unreported cases in the 2019-nCov epidemic outbreak in Wuhan, China, and the importance of major public health interventions</article-title>. <source>Biology</source>
<volume>9</volume>, <fpage>50</fpage>.</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal" id="cite5"><string-name><surname>Prem</surname>
<given-names>K</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan. China: a modelling study</article-title>. <source>The Lancet Public Health</source>
<volume>5</volume>, <fpage>e261</fpage>&#x02013;<lpage>e270</lpage>.<pub-id pub-id-type="pmid">32220655</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal" id="cite6"><string-name><surname>Nishiura</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Linton</surname>
<given-names>NM</given-names></string-name> and <string-name><surname>Akhmetzhanov</surname>
<given-names>AR</given-names></string-name> (<year>2020</year>) <article-title>Initial cluster of novel coronavirus (2019-nCoV) infections in Wuhan, China is consistent with substantial human-to-human transmission</article-title>. <source>Journal of Clinical Medicine</source>
<volume>9</volume>, <fpage>488</fpage>.</mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal" id="cite7"><string-name><surname>Nishiura</surname>
<given-names>H</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>The rate of under ascertainment of novel coronavirus (2019-nCoV) infection: estimation using Japanese passengers data on evacuation flights</article-title>. <source>Journal of Clinical Medicine</source>
<volume>9</volume>, <fpage>419</fpage>.</mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal" id="cite8"><string-name><surname>Roosa</surname>
<given-names>K</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020</article-title>. <source>Infectious Disease Modelling</source>
<volume>5</volume>, <fpage>256</fpage>&#x02013;<lpage>263</lpage>.<pub-id pub-id-type="pmid">32110742</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal" id="cite9"><string-name><surname>Volpert</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Banerjee</surname>
<given-names>M</given-names></string-name> and <string-name><surname>Petrovskii</surname>
<given-names>S</given-names></string-name> (<year>2020</year>) <article-title>A quarantine model of coronavirus infection and data analysis</article-title>. <source>Mathematical Modelling of Natural Phenomena</source>
<volume>15</volume>, <fpage>24</fpage>.</mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal" id="cite10"><string-name><surname>Diekmann</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Heesterbeek</surname>
<given-names>JAP</given-names></string-name> and <string-name><surname>Metz</surname>
<given-names>JAJ</given-names></string-name> (<year>1990</year>) <article-title>On the definition and the computation of the basic reproduction ratio <italic>R</italic><sub>0</sub> in models for infectious diseases in heterogeneous populations</article-title>. <source>Journal of Mathematical Biology</source>
<volume>28</volume>, <fpage>365</fpage>&#x02013;<lpage>382</lpage>.<pub-id pub-id-type="pmid">2117040</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal" id="cite11"><string-name><surname>van den Driessche</surname>
<given-names>P</given-names></string-name> and <string-name><surname>Watmough</surname>
<given-names>J</given-names></string-name> (<year>2002</year>) <article-title>Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission</article-title>. <source>Mathematical Biosciences</source>
<volume>180</volume>, <fpage>29</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">12387915</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal" id="cite12"><string-name><surname>Arino</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ducrot</surname>
<given-names>A</given-names></string-name> and <string-name><surname>Zongo</surname>
<given-names>P</given-names></string-name> (<year>2011</year>) <article-title>A metapopulation model for malaria with transmission-blocking partial immunity in hosts</article-title>. <source>Journal of Mathematical Biology</source>
<volume>64</volume>, <fpage>423</fpage>&#x02013;<lpage>448</lpage>.<pub-id pub-id-type="pmid">21442182</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal" id="cite13"><string-name><surname>Ducrot</surname>
<given-names>A</given-names></string-name>
<etal/> (<year>2009</year>) <article-title>A mathematical model for malaria involving differential susceptibility, exposedness and infectivity of human host</article-title>. <source>Journal of Biological Dynamics</source>
<volume>3</volume>, <fpage>574</fpage>&#x02013;<lpage>598</lpage>.<pub-id pub-id-type="pmid">22880962</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal" id="cite14"><string-name><surname>Hyman</surname>
<given-names>JM</given-names></string-name> and <string-name><surname>Li</surname>
<given-names>J</given-names></string-name> (<year>2000</year>) <article-title>An intuitive formulation for the reproductive number for the spread of diseases in heterogeneous populations</article-title>. <source>Mathematical Biosciences</source>
<volume>167</volume>, <fpage>65</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">10942787</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal" id="cite15"><string-name><surname>Zongo</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Dorville</surname>
<given-names>R</given-names></string-name> and <string-name><surname>Gouba</surname>
<given-names>E</given-names></string-name> (<year>2018</year>) <article-title>Method for identifying spatial reservoirs of malaria infection and control strategies</article-title>. <source>IAENG International Journal of Applied Mathematics</source>
<volume>48</volume>, <fpage>33</fpage>&#x02013;<lpage>39</lpage>. Available at <uri xlink:href="https://hal.univ-antilles.fr/hal-01706051/document">https://hal.univ-antilles.fr/hal-01706051/document</uri></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="other" id="cite16"><collab>Bilan d&#x000e9;mographique</collab> (<year>2019</year>) Available at <uri xlink:href="https://www.insee.fr/fr/statistiques/1892088?sommaire=1912926">https://www.insee.fr/fr/statistiques/1892088?sommaire=1912926</uri> (Accessed <date-in-citation content-type="access-date">05 May 2020</date-in-citation>).</mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal" id="cite17"><string-name><surname>Daniel</surname>
<given-names>P</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review</article-title>. <source>Annals of Internal Medicine</source> 173, 362-367. doi: <pub-id pub-id-type="doi">10.7326/M20-3012</pub-id>.</mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal" id="cite18"><string-name><surname>Day</surname>
<given-names>M</given-names></string-name> (<year>2020</year>) <article-title>COVID-19: four fifths of cases are asymptomatic, China figures indicate</article-title>. <source>BMJ</source>
<volume>369</volume>, <fpage>m1375</fpage>.<pub-id pub-id-type="pmid">32241884</pub-id></mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal" id="cite19"><string-name><surname>Nishiura</surname>
<given-names>H</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)</article-title>. <source>International Journal of Infectious Diseases</source>
<volume>94</volume>, <fpage>154</fpage>&#x02013;<lpage>155</lpage>. Available at <uri xlink:href="https://www.ijidonline.com/article/S1201-9712(20)30139-9/pdf">https://www.ijidonline.com/article/S1201-9712(20)30139-9/pdf</uri>.<pub-id pub-id-type="pmid">32179137</pub-id></mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal" id="cite20"><string-name><surname>Kenji</surname>
<given-names>M</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan</article-title>. <source>Eurosurveillance</source>
<volume>25</volume>, <fpage>12</fpage>.</mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal" id="cite21"><string-name><surname>Zhao</surname>
<given-names>H</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>COVID-19: asymptomatic carrier transmission is an underestimated problem</article-title>. <source>Epidemiology and Infection</source>
<volume>148</volume>, <fpage>1</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal" id="cite22"><string-name><surname>Lessler</surname>
<given-names>J</given-names></string-name>
<etal/> (<year>2009</year>) <article-title>Incubation periods of acute respiratory viral infections: a systematic review</article-title>. <source>The Lancet Infectious Diseases</source>
<volume>9</volume>, <fpage>291</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">19393959</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal" id="cite23"><string-name><surname>Backer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Klinkenberg</surname>
<given-names>D</given-names></string-name> and <string-name><surname>Wallinga</surname>
<given-names>J</given-names></string-name> (<year>2020</year>) <article-title>Incubation period of 2019 novel coronavirus (2019-nCov) infections among travellers from Wuhan, China, 20&#x02013;28 January 2020</article-title>. <source>Eurosurveillance</source>
<volume>25</volume>, pii=2000062. doi: <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.25.5.2000062</pub-id>.</mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="other" id="cite24"><collab>COVID-19 - France</collab> (<year>2020</year>) Available at <uri xlink:href="https://dashboard.covid19.data.gouv.fr/">https://dashboard.covid19.data.gouv.fr/</uri> (Accessed <date-in-citation content-type="access-date">05 May 2020</date-in-citation>).</mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="other" id="cite25"><collab>Tableaux de l&#x02019;&#x000e9;conomie fran&#x000e7;aise &#x000c9;dition</collab> (<year>2019</year>) Available at <uri xlink:href="https://www.insee.fr/fr/statistiques/3696937">https://www.insee.fr/fr/statistiques/3696937</uri> (Accessed <date-in-citation content-type="access-date">12 April 2020</date-in-citation>).</mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal" id="cite26"><string-name><surname>Li</surname>
<given-names>R</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)</article-title>. <source>Science (New York, N.Y.)</source>
<volume>368</volume>, <fpage>489</fpage>&#x02013;<lpage>493</lpage>.</mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal" id="cite27"><string-name><surname>Saurabh</surname>
<given-names>S</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Prolonged persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic infected individuals</article-title>. <source>QJM: An International Journal of Medicine</source>
<volume>113</volume>, <fpage>556</fpage>&#x02013;<lpage>560</lpage>. doi: <pub-id pub-id-type="doi">10.1093/qjmed/hcaa212</pub-id>.<pub-id pub-id-type="pmid">32609360</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="other" id="cite28"><string-name><surname>Zhang</surname>
<given-names>Z</given-names></string-name>
<etal/> (<year>2020</year>) Early viral clearance and antibody kinetics of COVID-19 among asymptomatic carriers . Preprint at medRxriv [published online ahead of print 2 May 2020]. Available at <pub-id pub-id-type="doi">10.1101/2020.04.28.20083139</pub-id>.</mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal" id="cite29"><string-name><surname>Yang</surname>
<given-names>L</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Viral dynamics in mild and severe cases of COVID-19</article-title>. <source>The Lancet Infectious Diseases</source>
<volume>20</volume>, <fpage>656</fpage>&#x02013;<lpage>657</lpage>.<pub-id pub-id-type="pmid">32199493</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal" id="cite30"><string-name><surname>Sun</surname>
<given-names>J</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Prolonged persistence of SARS-CoV-2 RNA in body fluids</article-title>. <source>Emerging Infectious Diseases</source>
<volume>26</volume>, <fpage>1834</fpage>&#x02013;<lpage>1838</lpage>.<pub-id pub-id-type="pmid">32383638</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal" id="cite31"><string-name><surname>Chinazzi</surname>
<given-names>M</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak</article-title>. <source>Science (New York, N.Y.)</source>
<volume>368</volume>, <fpage>395</fpage>&#x02013;<lpage>400</lpage>.</mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal" id="cite32"><string-name><surname>Kucharski</surname>
<given-names>AJ</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Early dynamics of transmission and control of COVID-19: a mathematical modelling study</article-title>. <source>The Lancet Infectious Diseases</source>
<volume>20</volume>, <fpage>553</fpage>&#x02013;<lpage>558</lpage>.<pub-id pub-id-type="pmid">32171059</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="other" id="cite33"><string-name><surname>Ong</surname>
<given-names>CWM</given-names></string-name> (<year>2020</year>) National Centre for Infectious Diseases, Chapter of Infectious Disease Physicians, Academy of Medicine Singapore. Period of Infectivity to Inform Strategies for De-isolation for COVID-19 Patients. Available at <uri xlink:href="https://scholarbank.nus.edu.sg/handle/10635/168938">https://scholarbank.nus.edu.sg/handle/10635/168938</uri>.</mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal" id="cite34"><string-name><surname>Zou</surname>
<given-names>L</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>SARS-CoV-2 viral load in upper respiratory specimens of infected patients</article-title>. <source>The New England Journal Medicine</source>
<volume>382</volume>, <fpage>1177</fpage>&#x02013;<lpage>1179</lpage>.</mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal" id="cite35"><string-name><surname>Long</surname>
<given-names>Q</given-names></string-name>
<etal/> (<year>2020</year>) <article-title>Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections</article-title>. <source>Nature Medicine</source> 26, 1200&#x02013;1204 . doi: <pub-id pub-id-type="doi">10.1038/s41591-020-0965-6</pub-id>.</mixed-citation></ref></ref-list><app-group id="appg1"><app id="app1"><title>Appendix</title><sec id="sec8" sec-type="other"><title/><sec id="sec8-1" sec-type="other"><title>Some details about the derivation of <inline-formula><inline-graphic xlink:href="S0950268820002162_inline26.jpg" mime-subtype="png" mimetype="image"/></inline-formula></title><p>In order to define <inline-formula><inline-graphic xlink:href="S0950268820002162_inline27.jpg" mime-subtype="png" mimetype="image"/></inline-formula> for model (<xref ref-type="disp-formula" rid="eqn1">1</xref>), we begin to find the disease-free equilibrium point by letting the compartments <italic>S</italic><sub>c</sub>, <italic>Q</italic>, <italic>E</italic>, <italic>I</italic><sub>r</sub>, <italic>I</italic><sub>u</sub>, and <italic>R</italic> be zero and <italic>S</italic><sub>u</sub>&#x000a0;=&#x000a0;<italic>S</italic><sub>u</sub>(0).</p><p>Let <inline-formula><inline-graphic xlink:href="S0950268820002162_inline28.jpg" mime-subtype="png" mimetype="image"/></inline-formula> denotes the inflow of new individuals into the infected classes <italic>I</italic><sub>r</sub>, <italic>I</italic><sub>u</sub>, <italic>E</italic> and <italic>Q</italic><disp-formula><graphic xlink:href="S0950268820002162_eqnU1.jpg" mime-subtype="png" position="float" mimetype="image" orientation="portrait"/></disp-formula>and <inline-formula><inline-graphic xlink:href="S0950268820002162_inline29.jpg" mime-subtype="png" mimetype="image"/></inline-formula> denotes all other flows within and out of the infected classes,<disp-formula><graphic xlink:href="S0950268820002162_eqnU2.jpg" mime-subtype="png" position="float" mimetype="image" orientation="portrait"/></disp-formula></p><p>Let <inline-formula><inline-graphic xlink:href="S0950268820002162_inline30.jpg" mime-subtype="png" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="S0950268820002162_inline31.jpg" mime-subtype="png" mimetype="image"/></inline-formula> be the Jacobian matrices of the maps <inline-formula><inline-graphic xlink:href="S0950268820002162_inline32.jpg" mime-subtype="png" mimetype="image"/></inline-formula> and <inline-formula><inline-graphic xlink:href="S0950268820002162_inline33.jpg" mime-subtype="png" mimetype="image"/></inline-formula>, respectively, evaluated at the disease free equilibrium:<disp-formula><graphic xlink:href="S0950268820002162_eqnU3.jpg" mime-subtype="png" position="float" mimetype="image" orientation="portrait"/></disp-formula></p><p>A straightforward computation shows that<disp-formula><graphic xlink:href="S0950268820002162_eqnU4.jpg" mime-subtype="png" position="float" mimetype="image" orientation="portrait"/></disp-formula></p><p>Following [<xref rid="ref11" ref-type="bibr">11</xref>], the matrix <italic>FV</italic><sup>&#x02212;1</sup> is well defined, and is the next-generation matrix and <inline-formula><inline-graphic xlink:href="S0950268820002162_inline34.jpg" mime-subtype="png" mimetype="image"/></inline-formula> is the spectral radius of <italic>FV</italic><sup>&#x02212;1</sup>.</p></sec></sec></app></app-group></back></article>